BDX – Becton, Dickinson and Company
Float Short %
1.15
Margin Of Safety %
23
Put/Call OI Ratio
0.7
EPS Next Q Diff
-0.45
EPS Last/This Y
8.49
EPS This/Next Y
0.51
Price
177.3
Target Price
204
Analyst Recom
2.38
Performance Q
0.23
Relative Volume
1.78
Beta
0.26
Ticker: BDX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-06 | BDX | 191.99 | 0.59 | 1.33 | 16321 |
| 2025-10-07 | BDX | 192.58 | 0.63 | 0.89 | 16524 |
| 2025-10-08 | BDX | 193.86 | 0.62 | 1.63 | 16539 |
| 2025-10-09 | BDX | 189.15 | 0.63 | 0.50 | 16651 |
| 2025-10-10 | BDX | 186.58 | 0.63 | 0.42 | 16721 |
| 2025-10-13 | BDX | 186.62 | 0.63 | 1.06 | 16727 |
| 2025-10-14 | BDX | 188.34 | 0.63 | 1.67 | 16866 |
| 2025-10-15 | BDX | 186.82 | 0.63 | 0.14 | 16925 |
| 2025-10-16 | BDX | 185.28 | 0.63 | 0.78 | 17017 |
| 2025-10-17 | BDX | 189.12 | 0.62 | 0.28 | 17289 |
| 2025-10-20 | BDX | 191 | 0.67 | 0.71 | 15332 |
| 2025-10-21 | BDX | 189.01 | 0.67 | 1.35 | 15796 |
| 2025-10-22 | BDX | 188.12 | 0.67 | 0.54 | 15945 |
| 2025-10-23 | BDX | 186.53 | 0.67 | 0.36 | 16070 |
| 2025-10-24 | BDX | 185.81 | 0.67 | 0.33 | 16232 |
| 2025-10-27 | BDX | 186.97 | 0.67 | 0.84 | 16314 |
| 2025-10-28 | BDX | 184.18 | 0.67 | 0.99 | 16433 |
| 2025-10-29 | BDX | 181.54 | 0.68 | 1.57 | 16501 |
| 2025-10-30 | BDX | 179.35 | 0.68 | 2.74 | 16625 |
| 2025-10-31 | BDX | 178.65 | 0.70 | 0.81 | 16819 |
| 2025-11-03 | BDX | 177.27 | 0.70 | 0.32 | 16836 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-06 | BDX | 192.01 | 2.8 | 527.8 | 14.37 |
| 2025-10-07 | BDX | 192.57 | 2.8 | 529.8 | 14.37 |
| 2025-10-08 | BDX | 193.91 | 2.8 | 539.2 | 14.37 |
| 2025-10-09 | BDX | 189.11 | 2.8 | 466.7 | 14.37 |
| 2025-10-10 | BDX | 186.59 | 2.8 | 493.4 | 14.37 |
| 2025-10-13 | BDX | 186.60 | 2.8 | 523.5 | 14.37 |
| 2025-10-14 | BDX | 188.30 | 2.8 | 542.7 | 14.37 |
| 2025-10-15 | BDX | 186.82 | 2.8 | 504.6 | 14.37 |
| 2025-10-16 | BDX | 185.29 | 2.8 | 505.2 | 14.37 |
| 2025-10-17 | BDX | 189.07 | 2.8 | 568.9 | 14.37 |
| 2025-10-20 | BDX | 191.05 | 2.7 | 546.2 | 14.37 |
| 2025-10-21 | BDX | 189.05 | 2.7 | 499.9 | 14.37 |
| 2025-10-22 | BDX | 188.11 | 2.7 | 512.0 | 14.37 |
| 2025-10-23 | BDX | 186.59 | 2.7 | 504.8 | 14.37 |
| 2025-10-24 | BDX | 185.88 | 2.7 | 515.2 | 14.37 |
| 2025-10-27 | BDX | 186.99 | 2.7 | 536.9 | 14.37 |
| 2025-10-28 | BDX | 184.21 | 2.7 | 489.0 | 14.37 |
| 2025-10-29 | BDX | 181.49 | 2.7 | 490.0 | 14.37 |
| 2025-10-30 | BDX | 179.38 | 2.7 | 496.7 | 14.37 |
| 2025-10-31 | BDX | 178.71 | 2.7 | 514.7 | 14.37 |
| 2025-11-03 | BDX | 177.30 | 2.7 | 505.5 | 14.37 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-06 | BDX | 0.12 | -0.16 | 1.50 |
| 2025-10-07 | BDX | 0.12 | -0.16 | 1.50 |
| 2025-10-08 | BDX | 0.12 | -0.16 | 1.50 |
| 2025-10-09 | BDX | 0.12 | -0.16 | 1.50 |
| 2025-10-10 | BDX | 0.12 | -0.16 | 1.34 |
| 2025-10-13 | BDX | 0.23 | -0.18 | 1.34 |
| 2025-10-14 | BDX | 0.23 | -0.18 | 1.34 |
| 2025-10-16 | BDX | 0.23 | -0.18 | 1.34 |
| 2025-10-17 | BDX | 0.23 | -0.18 | 1.34 |
| 2025-10-20 | BDX | 0.23 | -0.25 | 1.34 |
| 2025-10-21 | BDX | 0.23 | -0.25 | 1.34 |
| 2025-10-22 | BDX | 0.23 | -0.25 | 1.34 |
| 2025-10-23 | BDX | 0.23 | -0.25 | 1.34 |
| 2025-10-24 | BDX | 0.23 | -0.25 | 1.34 |
| 2025-10-27 | BDX | 0.23 | 0.59 | 1.15 |
| 2025-10-28 | BDX | 0.22 | 0.59 | 1.15 |
| 2025-10-29 | BDX | 0.21 | 0.59 | 1.15 |
| 2025-10-30 | BDX | 0.21 | 0.59 | 1.15 |
| 2025-10-31 | BDX | 0.21 | 0.59 | 1.15 |
| 2025-11-03 | BDX | 0.22 | 0.23 | 1.15 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.68
Avg. EPS Est. Current Quarter
3.92
Avg. EPS Est. Next Quarter
3.23
Insider Transactions
0.22
Institutional Transactions
0.23
Beta
0.26
Average Sales Estimate Current Quarter
5908
Average Sales Estimate Next Quarter
5381
Fair Value
217.9
Quality Score
68
Growth Score
84
Sentiment Score
45
Actual DrawDown %
38.3
Max Drawdown 5-Year %
-40.1
Target Price
204
P/E
31.88
Forward P/E
11.95
PEG
4.9
P/S
2.38
P/B
2
P/Free Cash Flow
19.93
EPS
5.56
Average EPS Est. Cur. Y
14.37
EPS Next Y. (Est.)
14.89
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
7.51
Relative Volume
1.78
Return on Equity vs Sector %
-19.5
Return on Equity vs Industry %
-2.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
505.5
Becton, Dickinson and CompanySector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 70000
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
stock quote shares BDX – Becton, Dickinson and Company Stock Price stock today
news today BDX – Becton, Dickinson and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch BDX – Becton, Dickinson and Company yahoo finance google finance
stock history BDX – Becton, Dickinson and Company invest stock market
stock prices BDX premarket after hours
ticker BDX fair value insiders trading